1. Home
  2. TTEK vs CYTK Comparison

TTEK vs CYTK Comparison

Compare TTEK & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

N/A

Current Price

$31.73

Market Cap

8.2B

ML Signal

N/A

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$60.05

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TTEK
CYTK
Founded
1966
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.6B
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
TTEK
CYTK
Price
$31.73
$60.05
Analyst Decision
Buy
Strong Buy
Analyst Count
3
18
Target Price
$44.00
$88.50
AVG Volume (30 Days)
2.4M
1.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
0.86%
N/A
EPS Growth
N/A
N/A
EPS
0.40
N/A
Revenue
$2,964,148,000.00
$13,368,000.00
Revenue This Year
N/A
$8.73
Revenue Next Year
$6.53
$309.93
P/E Ratio
$75.85
N/A
Revenue Growth
7.66
N/A
52 Week Low
$27.27
$29.31
52 Week High
$43.14
$70.98

Technical Indicators

Market Signals
Indicator
TTEK
CYTK
Relative Strength Index (RSI) 39.84 41.70
Support Level N/A $59.13
Resistance Level $34.96 $65.27
Average True Range (ATR) 1.23 2.54
MACD -0.18 -0.08
Stochastic Oscillator 27.71 25.92

Price Performance

Historical Comparison
TTEK
CYTK

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: